GlassScriptPhysician profile
Benjamin W Stevens
NPI 1295953172
$17,374.02
in general payments reported to CMS, 2019-2025
12 companies · $608 in 2025
The $608 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $658 · 2020: $664 · 2021: $6,471 · 2022: $6,880 · 2023: $1,439 · 2024: $654 · 2025: $608.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,801 · Consulting Fee: $900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,801.03 |
| Consulting Fee | $900.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $14,160.45 | 2021-2023 | Va-Lcp, Lcp, Na |
| Depuy Synthes Sales INC. | $1,276.99 | 2019-2025 | Hammerlock, Tfn-Advance, Fibulink |
| Synthes USA Products LLC | $448.29 | 2020 | |
| Wright Medical Technology, INC. | $398.72 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $283.40 | 2023-2025 | Comprehensive Shoulder System, A.L.P.S. |
| Medartis INC. | $268.78 | 2024-2025 | Aptus |
| Stryker Corporation | $200.06 | 2024-2025 | Inbone, Citrefix, Infinity Adaptis |
| Kerecis Limited | $143.68 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Paragon 28, INC. | $90.05 | 2023-2025 | Additive Orthopedics, Portfolio, Total Talus |
| Horizon Therapeutics Plc | $55.85 | 2020-2021 | |
| Biocomposites INC | $29.92 | 2024 | |
| Bioventus LLC | $17.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Stevens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.